In addition, as shown in Figure 5, expression ratios of PCNA (a proliferation marker), survivin and bcl-2 (both anti-apoptosis markers) in tumor cells of the control animals were greater than those of treated rats with BM-06, sorafenib, poly(I:C) and BM-06 plus sorafenib groups. Here, BIRC5 is linked to neoplasm.